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Autosomal recessive ichthyosis (ARI) includes a heterogeneous group of disorders of keratinization characterized
by desquamation over the whole body. Two forms largely limited to the skin have been defined: lamellar ichthyosis
(LI) and nonbullous congenital ichthyosiform erythroderma (NCIE). A first gene for LI, transglutaminase TGM1,
has been identified on chromosome 14, and a second one has been localized on chromosome 2. In a genomewide
scan of nine large consanguineous families, using homozygosity mapping, two new loci for ARI were found, one
for a lamellar form in a 6-cM interval on chromosome 19 and a second for an erythrodermic form in a 7.7-cM
interval on chromosome 3. Linkage to one of the four loci could be demonstrated in more than half of 51
consanguineous families, most of them from the Mediterranean basin. All four loci could be excluded in the others,
implying further genetic heterogeneity in this disorder. Multipoint linkage analysis gave maximal LOD scores of
11.25 at locus D19S566 and 8.53 at locus D3S3564.
Introduction
Ichthyosis, from the Greek word ichthys (fish), is the
common name for a heterogeneous group of disorders
characterized by scaling over the whole body. Twomajor
forms have been described clinically: (1) the primary
forms, in which the disorder is largely limited to the
skin, and (2) the ichthyosiform syndromes, in which ich-
thyosis is a part of a multisystem disorder. In the first
group, two major forms have been defined, lamellar ich-
thyosis (LI; MIM 242300, MIM 601277) and nonbul-
lous congenital ichthyosiform erythroderma (NCIE;
MIM 242100). The existence of supplementary clinical
symptoms denotes ichthyosiform syndromes such as Sjo¨-
gren-Larsson syndrome (MIM 270200), which is char-
acterized by spastic paraplegia, mental retardation, and
retinopathy in addition to ichthyosis (Sjo¨gren and Lars-
son 1957), or Refsum syndrome (MIM 266500), in
which retinitis pigmentosa, cataracts, deafness, cerebel-
lar ataxia, and polyneuropathy are also present (Refsum
1946). Different forms of congenital ichthyosis may also
be distinguished by the mode of inheritance: autosomal
dominant (ichthyosis vulgaris (MIM 146700) and a rare
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form of lamellar ichthyosis (MIM 146750 [Traupe et al.
1984]), X-linked recessive ichthyosis (XLRI; MIM
308100), and autosomal recessive ichthyosis (ARI).
LI, which is almost always autosomal recessive, is also
referred to as “nonerythrodermic ichthyosis.” It is char-
acterized by the presence of large, dark, platelike, firmly
adherent scales in the absence of erythroderma. The
incidence of LI is estimated to be 1/500,000 (Griffiths
et al. 1998). Most of these patients are born as collodion
babies (CB) and often show a marked involvement of
the face and the ears. Ectropion and eclabion, palmo-
plantar keratoderma, and scarring alopecia may also be
present. Histologic characteristics are orthohyperkera-
tosis and mild focal parakeratosis with a normal or
increased granular layer. LI is considered to be a reten-
tion ichthyosis due to a defect in cornification or ter-
minal epidermal differentiation (Hazell and Marks
1985).
NCIE, which is also autosomal recessive, is an in-
flammatory form of ichthyosis with an estimated fre-
quency of 1/300,000 (Griffiths et al. 1998). It is char-
acterized by prominent erythroderma and fine white,
superficial, semiadherent scales. As many as 90% of
affected individuals present as CBs at birth. Patients
suffer from palmoplantar keratoderma, often with pain-
ful fissures, digital contractures, and loss of pulp vol-
ume. In half of the cases, a nail dystrophy including
ridging, subungeal hyperkeratosis, or hypoplasia has
been described. Ectropion, eclabion, scalp involvement,
and loss of eyebrows and lashes seem to be much more
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frequent in NCIE than in LI. Histologic features such
as hyperkeratosis, an increase in stratum corneum thick-
ness, a normal or prominent granular layer, and in-
creased mitoses point to a hyperproliferative epidermal
defect (Griffiths et al. 1998). Prominent dermal blood
vessels and an upper dermal lymphocytic infiltrate may
explain the erythroderma.
Clinical differentiation of the two phenotypes of ARI
is not straightforward. Both forms usually present as
CBs at birth, in which case the affected infants are
encased in a translucent pergament-like collodion
membrane that is due to a defective stratum corneum.
This is a transient syndrome limited to the first few
weeks after birth, which may subsequently develop into
either LI or NCIE. Furthermore, there may be inter-
mediate forms in which the disease resembles LI on
some parts of the skin and NCIE on other areas. The
symptoms may be modified by treatment, but even in
the absence of therapeutic intervention, clinical differ-
entiation may be difficult (Williams and Shwayder
1995). Attempts to refine the categorization of ARI us-
ing clinical (Traupe 1989), biochemical (Bergers et al.
1990), and ultrastructural observations (Anton-Lam-
brecht and Schnyder 1974) have failed to yield a con-
sistent and replicable classification scheme. Even for a
defined genotype such as that due to mutations in the
TGM1 (MIM 190195) gene, the samemutation can give
rise to either LI or NCIE. Moreover, there are no clear
clinical differences between patients with TGM1 mu-
tations and those without linkage to the TGM1 locus
(Laiho et al. 1997; Hennies et al. 1998).
To date, two genes for ARI have been localized and
one of them identified. Mutations in keratinocyte trans-
glutaminase TGM1 on chromosome 14 have been
found to be associated with LI in a subset of patients
(Huber et al. 1995; Parmentier et al. 1995; Russell et
al. 1995). A second gene for LI has been localized to a
2.2-Mb interval on chromosome 2q34 in a North Af-
rican population (Parmentier et al. 1999).
Here we report two additional loci for ARI, which
were identified in consanguineous families of different
origins: a lamellar form on chromosome 19 in six fam-
ilies and an erythrodermic form on chromosome 3, also
in six families.
Subjects and Methods
Subjects and Samples
A large number of DNA samples from families af-
fected by ARI have been collected at Ge´ne´thon since
1994. Fifty-one consanguineous families from Algeria,
France, Morocco, Tunisia, and Turkey were selected
from this large collection of 195 families. All patients
were examined by a dermatologist (B.B., C.B-B., or A.K.)
who established the pedigree information and a medical
and dermatologic history. Particular attention was given
to the presence of supplementary neurologic and oph-
thalmologic symptoms and examination of hair, teeth,
and mucosal membranes in order to include only pure
forms of LI and NCIE. After informed consent was ob-
tained, blood samples were collected and DNA was ex-
tracted from whole blood by means of standard
procedures.
Fluorescent Genome Mapping and Nonfluorescent
Genotyping of Consanguineous Families
Initially, nine consanguineous families (lot 1) with at
least two affected children and not exhibiting linkage to
the known localization on chromosome 14 (TGM1)
were selected for a genomewide scan using 260 poly-
morphic microsatellite markers from the Ge´ne´thonmap,
spaced at an average distance of 15 cM (Dib et al. 1996).
After the identification of two additional loci for ARI
in 4 of these 9 families, we analyzed 42 supplementary
families (lot 2), using an exclusion panel with a total of
15 markers for the four localizations. Altogether, a total
of 51 families were analyzed by homozygosity mapping
(Lander and Botstein 1987).
The forward primers were modified with FAM, TET,
or HEX fluorescent labels. PCR reactions were per-
formed in a final volume of 15 ml containing 30 ng of
DNA, 2.5 mmol dNTP, 1.5 mmol buffer, 5 mmol of each
primer, and 0.5 IU Taq polymerase. After an initial de-
naturation for 5 min at 96C (first cycle) the enzyme
was added at 94C (second cycle). After the hot start,
30 cycles at 94C for 30 s, 55C for 40 s, and 72C for
30 s were performed before the final elongation at 72C
for 10 min. The pooled PCR products were loaded on
a 4.25% polyacrylamide-6 M urea gel and run on a 373
DNA sequencer (Applied Biosystems). The results were
processed by GENESCAN 2.0.2 and GENOTYPER 1.1
software.
PCR reactions with nonfluorescent markers were per-
formed in a 50 ml final volume containing 100 ng of
DNA, 6 mmol dNTP, buffer, 50 mmol of each primer,
and 1 IU Taq polymerase. The remaining PCR condi-
tions were identical to those described above (Vignal et
al. 1993).
Linkage and Haplotype Analysis
Linkage programs were used on the assumption of
autosomal recessive inheritance, full penetrance, and a
disease frequency of 1/300,000 for NCIE and 1/500,000
for LI. The alleles were considered to be isofrequent.
Pairwise LOD scores were calculated with the MLINK
program of the LINKAGE 5.1 package (Lathrop et al.
1985), incorporating consanguineous loops into the ped-
igree files. We used the GENEHUNTER program to con-
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struct the haplotypes of each individual and MAP-
MAKER/HOMOZ to calculate multipoint location
scores (Kruglyak et al. 1996). The HOMOGM program
was used to analyze the genetic heterogeneity for the
four independent disease loci and to determine the pro-
portion of families without linkage (Bhat et al. 1999).
Results
Linkage and Haplotype Analysis
Genomewide scan in nine families (Lot 1).—A ge-
nomewide scan was performed in the nine large con-
sanguineous families of lot 1. Two families had three
affected children, and seven families had two affected
children. In all cases, the DNA from both parents was
available. Sixty individuals were genotyped, of whom
20 were affected. A total of 58 markers were found to
be homozygous in the affected individuals in these nine
families. Ten loci, for which the markers were homo-
zygous in the patients and heterozygous in the parents
and unaffected siblings, were tested with supplementary
unlabeled primers to confirm or exclude the existence of
a larger homozygous region. In this lot, three families
(A1, A2, A3) showed strong evidence for linkage to chro-
mosome 19 (fig. 1) with a maximal LOD score (Zmax)
of 3.69 at recombination fraction (v) = 0 for D19S414.
One family (B1) showed a large homozygous region on
chromosome 3 (fig. 2) with a Zmax of 1.47 at forv = 0
D3S1578. Two families showed linkage to the chro-
mosome 2 locus (data not shown).
Analysis of the four candidate regions in 42 families
(Lot 2).—In the second stage, we selected 42 supple-
mentary consanguineous families (lot 2) for linkage anal-
yses on chromosomes 2, 3, 14, and 19. There were 280
family members, of whom 52 subjects were affected,
including one family with three affected and eight fam-
ilies with two affected individuals. We found 3 of these
42 families linked to chromosome 2 (data not shown)
and 5 to the chromosome 3 locus (B2, B3, B4, B5, B6)
(fig. 2). Eleven were found to be linked to chromosome
14 (data not shown), and three others (A4, A5, A6) (fig.
1) were linked to the chromosome 19 locus.
Saturation of individuals from families A1 to A6 with
a total of 29 markers from chromosome 19 showed ho-
mozygous regions ranging between 9 cM and 43 cM for
the affected individuals (fig. 3). The maximal pairwise
LOD score for these 6 families with linkage to chro-
mosome 19 for the marker AFMa123xf1 (D19S566) at
was 8.64 (table 1). Multipoint analysis resulted inv = 0
a Zmax of 11.25 at the same locus. The haplotypes were
constructed under the assumption of the most parsi-
monious linkage phase (fig. 1). The smallest cosegre-
gating interval of 6 cM was defined by the marker
AFMb021yb9 (D19S899) at the upper telomeric limit
and by the marker AFM205yf10 (D19S405) at the lower
telomeric limit (fig. 3). The definition of the upper limit
was based on a recombination event in the nonaffected
child (e1) in family A1. The upper limit defined by a
recombination event in an affected child was
AFMa357zd9 (D19S892), 2 cM more telomeric. The
lower limit is defined by loss of homozygosity in an
affected child (e1) in family A5 (fig. 1)
On chromosome 3, we analyzed 33 markers and ob-
served homozygous regions spanning 10–29 cM. The
maximal pairwise LOD score for the six families with
linkage to chromosome 3 for the marker AFM a162wd9
(D3S3564) at was 6.33 (table 2), whereas the mul-v = 0
tipoint LOD score at the same locus was 8.53. The small-
est cosegregating region of 7.7 cM is defined by loss of
homozygosity in affected children (fig. 4). It was limited
by the marker AFM349ta5 (D3S3522) in the affected
individual e1 from family B2 and by the marker
AFM273ve9 (D3S1581) in patient e1 from family B4
(fig. 2).
The haplotypes for both loci were different between
the families, even in the families from the same country,
but a smaller common haplotype cannot been excluded.
Linkage to these four loci was excluded in more than
half of the 51 families by linkage analysis and the ab-
sence of homozygous regions at these loci.
The HOMOGM program was run with one marker
for each of the four localizations (D2S143, D3S3637,
D14S1032, and D19S568). This program calculates the
probability for each family to show linkage to one of
the loci but also the proportion of families without link-
age to any of the analyzed loci. The results of this pro-
gram indicate linkage to chromosome 2 in 7% of the
families; chromosome 3, 22%; chromosome 14, 21%;
and chromosome 19, 35%. Sixteen percent of the 51
families were considered to be without linkage to any
of the four loci analyzed.
Clinical Data
These 51 families had different geographic origins, but
most of them came from Mediterranean countries. Of
the chromosome 19 families, three were from North Af-
rica and one each from France, the Antilles, and Turkey.
A total of 10 individuals were affected and 22 unaf-
fected. The parents in families A1, A3, A4 , and A5 were
first cousins, whereas in family A2 and A6 the parents
were second cousins. The patients in five of the six fam-
ilies with linkage to chromosome 19 were born as CBs,
whereas in the Turkish family A6 neither of the affected
children presented a CB syndrome at birth. All of these
patients presented the clinical features typical of lamellar
ichthyosis, with large brownish adherent scales and pal-
moplantar hyperkeratosis, although in this last family
(A6) neither erythema nor ectropion and eclabion had
Figure 1 Pedigrees of six consanguineous nuclear LI families with linkage to chromosome 19. Haplotypes for 29 microsatellite markers from chromosome 19p12-q12 are shown. Affected
individuals are indicated by blackened symbols, and the homozygous region that segregates with the disease phenotype is circled.
Figure 2 Pedigrees of six consanguineous nuclear NCIE families with linkage to chromosome 3. Haplotypes for 33 microsatellite markers from chromosome 3p21 are shown. Affected individuals
are indicated by blackened symbols, and the homozygous region that segregates with the disease phenotype is circled.
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Figure 3 Limits of the common interval (shaded) in the chro-
mosome 19–linked LI families.
been observed. Hair, nails, and teeth were not affected.
All six families with linkage to chromosome 3 (B1–B6)
came from Mediterranean countries—five from North
Africa, and one from Turkey. The parents of the 7 af-
fected and 10 unaffected children were first cousins. All
the affected children were born as CBs and showed a
widespread intense erythema with fine white scales all
over the body. In addition to erythema and palmoplantar
hyperkeratosis, the patient in family B4 exhibited ectro-
pion, eclabion, and diffuse alopecia with eroded plaques
on the scalp. Hair, nails, and teeth were normal.
Discussion
The clinical and genetic heterogeneity of ARI combined
with the small number of patients in affected families
have hampered traditional approaches to gene mapping.
We have used homozygosity mapping of consanguineous
families, which is a relatively simple and powerful
method for localization of genes in autosomal recessive
disorders; only a small number of affected individuals
are required to obtain a high LOD score. According to
Lander and Botstein (1987), a single affected child of a
first-cousin marriage contains the same linkage infor-
mation as a nuclear family with three affected children.
In the present study, analysis of 51 consanguineous fam-
ilies from different geographic backgrounds that are af-
fected by ARI demonstrates once again the genetic het-
erogeneity of this disorder and has permitted us to define
two new loci for ARI. Eleven families (22%) showed
linkage to chromosome 14, whereas 10% (5 of 51)
showed linkage to chromosome 2. We found six families
(12%) with linkage to the new locus on chromosome
19 and six (12%) others with linkage to the new locus
on chromosome 3. The proportion of families with link-
age to a defined locus varied between countries and der-
matology clinics, but up to 70% of the ARI localizations
are now known in some groups. The new version of
HOMOGM program (Bhat et al. 1999) made it possible
for us to analyze the genetic heterogeneity of this dis-
order with four loci simultaneously. Good correspon-
dence between the results of this program and the link-
age analysis of homozygous regions was found on
chromosome 14 (22% vs. 21%) and chromosome 2 (7%
vs. 10%), but the proportion of families with linkage to
chromosome 3 (12% vs. 20%) and chromosome 19
(12% vs. 35%) by HOMOGM was overestimated. This
discrepancy could be due to the fact that in small families
with only one patient the analyzed marker can be ho-
mozygous in the affected individual by chance, so the
proportion could be overestimated.
Clinically, most of our patients with linkage to chro-
mosomes 2, 14, and 19 showed the typical clinical fea-
tures of LI; they represent almost half (43%) of the
patients with ARI. Six families representing 12% of the
analyzed population show linkage to the second new
locus on chromosome 3, and their clinical symptoms
are more typical of NCIE. Obviously, more analyses are
needed to differentiate the clinical picture of the patients
with the two forms of ARI; the new localizations should
help to better define these clinical entities. Because all
of our patients with linkage to chromosome 3 presented
the clinical features typical of NCIE, whereas those with
linkage to chromosome 19 showed symptoms of LI, it
seems that there is less phenotypic variation in our two
new localizations than in the chromosome 14 locali-
zation (TMG1). The patients with ichthyosis localized
to chromosome 2 all present ichthyosis of the lamellar
type. Since no localization was detected in 45% of the
families, at least one other gene (and probably more)
must be implicated in ARI.
The only gene identification to date for an autosomal
recessive form of ichthyosis limited to the skin is that
910 Am. J. Hum. Genet. 66:904–913, 2000
Table 1
Combined Pairwise LOD Scores for the Six LI Families for Markers in the Common Interval on Chromosome
19
MARKER
AFM
NUMBER
LOD SCORE AT v =
Zmax vmax0 .01 .05 .10 .20 .30 .40
D19S884 b299wb1 20.46 7.83 3.85 2.19 .83 .29 .06 0 .50
D19S916 b325wa5 10.21 2.19 .08 .58 .77 .55 .26 .78 .17
D19S906 b055zc9 5.66 2.07 .26 .40 .62 .41 .14 .63 .18
D19S892 a357zd9 3.28 4.00 4.38 4.03 2.86 1.64 .65 4.39 .06
D19S930 a050yc5 6.63 6.89 6.59 5.8 3.99 2.28 .91 6.91 .03
D19S899 b021yb9 6.86 6.68 5.97 5.09 3.38 1.87 .72 6.86 0
D19S410 278xc5 5.85 5.69 5.08 4.32 2.87 1.61 .65 5.85 0
D19S212 143xe9 6.21 6.02 5.33 4.47 2.85 1.52 .54 6.21 0
D19S566 a123xf1 8.64 8.42 7.53 6.43 4.28 2.39 .93 8.64 0
D19S898 b019xe1 6.98 6.79 6.05 5.12 3.34 1.81 .69 6.98 0
D19S895 b007xb9 7.52 7.32 6.55 5.59 3.72 2.06 .79 7.52 0
D19S915 234xf4 6.20 6.05 5.43 4.65 3.13 1.74 .65 6.20 0
D19S925 b355yd1 3.59 3.48 3.04 2.51 1.55 .81 .31 3.59 0
D19S407 214yf6 7.25 7.14 6.56 5.72 3.94 2.27 .92 7.25 0
D19S911 b293yg9 4.75 4.63 4.14 3.49 2.24 1.17 .42 4.75 0
D19S568 344yg5 6.39 6.26 5.66 4.84 3.16 1.69 .60 6.39 0
D19S419 326xb1 3.48 3.37 2.93 2.41 1.46 .73 .24 3.48 0
D19S931 a058xc5 8.12 7.91 7.09 6.06 4.05 2.26 .86 8.12 0
D19S875 a224wc9 7.28 7.09 6.32 5.36 3.53 1.93 .73 7.28 0
D19S870 a190yg9 6.50 6.32 5.60 4.72 3.04 1.63 .59 6.50 0
D19S932 a084xf1 5.99 5.83 5.16 4.34 2.80 1.50 .56 5.99 0
D19S919 b332xe5 5.98 5.84 5.24 4.44 2.87 1.52 .54 5.98 0
D19S409 269xg5 5.91 5.75 5.09 4.28 2.74 1.44 .51 5.91 0
D19S405 205yf10 3.44 3.71 3.66 3.21 2.11 1.11 .39 3.72 .02
D19S928 c021wd1 3.21 3.11 2.72 2.23 1.33 .63 .18 3.21 0
D19S871 a190zh5 4.88 4.74 4.18 3.50 2.24 1.17 .40 4.88 0
D19S414 295xg9_b 3.37 4.01 4.14 3.74 2.64 1.53 .62 4.18 .03
D19S225 248zc1 3.70 3.97 3.90 3.42 2.30 1.26 .47 2.71 .03
D19S868 a154xg1 0.47 3.08 3.58 3.34 2.38 1.35 .52 3.61 .07
of transglutaminase 1 (TGM1), which encodes an en-
zyme that catalyzes the formation of isodipeptide bonds
between proteins of the cornified envelope of the skin,
such as loricrin and involucrin, during terminal stages
of epidermal differentiation (Russell et al. 1995). Several
of the genes for other forms of ichthyosis that have been
isolated to date are implicated in the metabolism of
lipids. In XLRI there is a deficiency in steroid sulfatase,
which interrupts the synthesis of cholesterol from cho-
lesterol sulfate (Webster et al. 1978); accumulation of
the latter gives rise to a barrier abnormality leading to
a retentional ichthyosis (Elias et al. 1984). Sjo¨gren-Lars-
son syndrome is due to a mutation in the fatty aldehyde
dehydrogenase gene FALDH (MIM 100660) (De Lau-
renzi et al. 1996). Refsum syndrome is also an inborn
error of lipid metabolism and is caused by mutations
in the phytanoyl-CoA hydroxylase gene PHYH (MIM
602026) (Jansen et al. 1997). PHYH is a peroxisomal
protein that catalyzes the first step in a-oxidation of
phytanic acid. The fact that reversible symptoms of ich-
thyosis may be a side effect of treatments with certain
drugs that affect lipid metabolism, especially choles-
terol-lowering drugs (Williams and Schwayder 1995),
also suggests a role for lipid metabolism defects in this
disorder.
The Human Gene Map lists large numbers of genes
and ESTs in the two new localization intervals: 510 ESTs
including 81 genes in the 7.7-cM interval on chromo-
some 3 and 110 ESTs including 20 genes in the 6-cM
interval on chromosome 19. Within these intervals there
are several possible candidate genes, including at least
one transglutaminase and several genes involved in lipid
metabolism.
Because mutations in keratinocyte transglutaminase
(TGM1) are already known to be responsible for ARI,
transglutaminase 4 (TGM4; MIM 600585), which has
been localized to 3p21, would seem to be an interesting
candidate gene, but it has been found to be expressed
only in prostate tissue to date (Dubbink et al. 1996).
Another transglutaminase has recently been isolated by
reverse transcriptase-PCR of keratinocyte mRNA with
degenerate primers based on the conserved transglutam-
inase active site region (Aeschlimann et al. 1998); its
localization is not yet known. Genes involved in lipid
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Table 2
Combined Pairwise LOD Scores for the Six NCIE Families for Markers in the Common Interval on
Chromosome 3
MARKER
AFM
NUMBER
LOD SCORE AT v =
Zmax vmax0 .01 .05 .10 .20 .30 .40
D3S1266 095xc1_b .96 .01 .95 1.18 .96 .56 .21 1.21 .11
D3S3727 a090zb1 2.37 1.28 .02 .40 .45 .25 .06 .47 .19
D3S1619 350tf1 2.76 1.48 .22 .18 .27 .11 .01 .27 .20
D3S3518 331wh9 4.39 2.77 1.02 .35 0 .01 .05 0 .20
D3S1277 164we1 2.21 1.14 .06 .42 .43 .22 .06 .45 .02
D3S3639 b314yh1 1.48 .07 .75 .89 .66 .33 .08 .93 .12
D3S1298 220yb8 4.58 .74 .61 .91 .78 .44 .16 .95 .13
D3S3527 a073yf5 2.29 .80 .20 .45 .42 .24 .08 .48 .12
D3S3658 b330ze5 1.26 1.71 1.91 1.72 1.12 .56 .18 1.95 .07
D3S3522 349ta5 1.89 2.50 2.64 2.35 1.55 .82 .29 2.68 .04
D3S3678 b362yc1 4.02 3.90 3.44 2.87 1.81 .94 .33 4.02 0
D3S3559 a139wf9 4.99 4.86 4.04 3.69 2.46 1.39 .47 4.99 0
D3S3564 a162wd9 6.33 6.16 4.47 4.62 3.02 1.65 .66 6.33 0
D3S3597 a344zg5 5.53 5.37 4.72 3.94 2.50 1.36 .55 5.53 0
D3S3647 b320vc1 4.24 4.12 3.63 3.04 1.94 1.02 .36 4.24 0
D3S3582 a231xe9 3.19 3.20 3.00 2.59 1.68 .88 .32 3.20 .01
D3S1581 273ve9 3.32 3.55 3.55 3.26 2.29 1.27 .53 3.55 .01
D3S1573 126xg7 1.53 1.82 1.96 1.77 1.19 .62 .20 1.99 .04
D3S3615 b049zf9 1.67 1.95 2.09 1.90 1.31 .73 .27 2.09 .04
D3S3667 b348za9 1.67 1.96 2.11 1.92 1.34 .76 .31 2.11 .05
D3S1578 268wg9_b .92 .44 1.55 1.76 1.42 .86 .36 1.79 .09
D3S1613 340xf1 1.13 2.41 2.61 2.31 1.51 .80 .30 2.63 .07
D3S3719 a071yd1 1.82 2.11 2.28 2.11 1.54 .92 .40 2.29 .04
D3S3717 a066wd5 .17 1.92 2.39 2.21 1.50 .83 .34 2.45 .06
D3S1606 318wc5 .84 .73 1.84 1.98 1.52 .90 .37 2.01 .11
D3S3721 a072yb9 1.84 1.33 2.75 2.60 1.87 1.08 .44 2.78 .06
D3S3588 a275zh1 1.38 1.78 1.87 1.66 1.19 .73 .33 1.89 .04
D3S3724 a082wh1 2.80 1.39 .12 .62 .71 .48 .21 .74 .18
D3S3621 b283ya5 .83 .09 .85 .95 .69 .36 .12 .97 .08
D3S3616 b059wf1 .63 1.27 2.02 2.08 1.59 .93 .36 2.08 .10
D3S1295 210yc5 .30 .85 1.58 1.71 1.38 .85 .37 1.72 .09
D3S3722 a072zh5 2.82 .52 1.35 1.53 1.20 .69 .28 1.53 .10
D3S1300 220yh4_t 5.27 1.91 .28 .19 .31 .18 .06 .32 .19
metabolism in the chromosome 3 interval include
an acetyl-coenzyme acyltransferase (ACAA1; MIM
604054) and sterol 12-a-hydroxylase (CYP8B1; MIM
602172), a microsomal cytochrome P450 enzyme in-
volved in bile acid synthesis from cholesterol. Other
possible candidate genes in the chromosome 3 interval
include a laminin receptor (LAMR1; MIM 150370) and
a-1 collagen type VII (COL7A1; MIM 120120), which
is highly expressed in epidermal keratinocytes. The tri-
ple helix of this long-chain collagen consists of three
identical alpha chains. Collagen VII is mainly present
as anchoring fibrils that are situated in the dermal-epi-
dermal basement membrane zone. Mutations in the
COL7A1 gene have been identified in several forms of
dystrophic epidermolysis bullosa. Point mutations in
COL7A1 have recently been described in a patient with
transient bullous dermolysis of the newborn, which is
characterized by spontaneous healing or dramatic im-
provement of the lesions within the first month of life
(Hammami-Hauasli et al. 1998). This has a common
point with the CB syndrome, for which five spontane-
ously healing cases in a large Swiss kindred have been
reported (Frenk and de Techtermann 1992).
In the chromosome 19 interval, there is a gene for a
prostaglandin E2 receptor (PTGER1; MIM 176802),
which is of interest because endogenous prostaglandin
E2 has been shown to be involved in the differentiation
of keratinocytes (Evans et al. 1993). Genes involved in
the cytochrome c reductase complex are found in both
the new intervals UQCRC1 (MIM 191328) on chro-
mosome 3 and UQCRFS1 (MIM 191327) on chro-
mosome 19), as are genes for zinc finger proteins and
protein kinase C. There is a microtubule-associated pro-
tein gene in the chromosome 3 interval (MAP4; MIM
157132) and another one (MAP2; MIM 157130) in the
ARI interval on chromosome 2.
These two new intervals will need to be narrowed by
analysis of additional affected families and development
912 Am. J. Hum. Genet. 66:904–913, 2000
Figure 4 Limits of the common interval (shaded) in the chro-
mosome 3–linked NCIE families.
of new markers, before a gene search can be initiated.
The eventual identification and characterization of the
defects responsible for ARI should lead to a better un-
derstanding of the pathogenic mechanisms in these dis-
orders and to strategies for therapeutic intervention.
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